The efficacy of group metacognitive therapy for children (MCT-c) with generalized anxiety disorder: An open trial
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The efficacy of group metacognitive therapy for children (MCT-c) with generalized anxiety disorder: An open trial. / Esbjørn, Barbara Hoff; Normann, Nicoline; Christiansen, Bianca Munkebo; Reinholdt-Dunne, Marie Louise.
In: Journal of Anxiety Disorders, Vol. 53, 01.2018, p. 16-21.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The efficacy of group metacognitive therapy for children (MCT-c) with generalized anxiety disorder: An open trial
AU - Esbjørn, Barbara Hoff
AU - Normann, Nicoline
AU - Christiansen, Bianca Munkebo
AU - Reinholdt-Dunne, Marie Louise
N1 - Copyright © 2017 Elsevier Ltd. All rights reserved.
PY - 2018/1
Y1 - 2018/1
N2 - Metacognitive therapy is an effective treatment for anxiety disorders in adults. Studies have demonstrated that the underlying theoretical model is also supported in children. It has therefore been suggested that metacognitive therapy for children may be effective. Our study is an open trial of metacognitive therapy for children with generalized anxiety as their primary disorder. Therapy was provided in groups. Families were interviewed with the Anxiety Disorders Interview Schedule - child/parent versions. They reported on the child's anxiety levels using the Revised Childrens Anxiety and Depression Scale - child/parent versions. Children reported on metacognitive beliefs using the Metacognitions Questionnaire for Children - 30 item version. Fourty-four children aged 7-13 years (50% girls) were enrolled, and one family dropped out during treatment. Fifty percent of the children had received counseling or psychological treatment for their anxiety disorder previously. Following treatment, 86.4% of the children were free of their primary disorder and 72.7% were free of all anxiety disorders, the corresponding figures were 75% and 65.9% at 6-months follow-up. The effect sizes were large for all measures and clinically significant improvements were obtained for 70% of the children at posttest and 77% at follow-up. Our study suggests that metacognitive therapy for children with generalized anxiety disorder may be a highly promising treatment approach.
AB - Metacognitive therapy is an effective treatment for anxiety disorders in adults. Studies have demonstrated that the underlying theoretical model is also supported in children. It has therefore been suggested that metacognitive therapy for children may be effective. Our study is an open trial of metacognitive therapy for children with generalized anxiety as their primary disorder. Therapy was provided in groups. Families were interviewed with the Anxiety Disorders Interview Schedule - child/parent versions. They reported on the child's anxiety levels using the Revised Childrens Anxiety and Depression Scale - child/parent versions. Children reported on metacognitive beliefs using the Metacognitions Questionnaire for Children - 30 item version. Fourty-four children aged 7-13 years (50% girls) were enrolled, and one family dropped out during treatment. Fifty percent of the children had received counseling or psychological treatment for their anxiety disorder previously. Following treatment, 86.4% of the children were free of their primary disorder and 72.7% were free of all anxiety disorders, the corresponding figures were 75% and 65.9% at 6-months follow-up. The effect sizes were large for all measures and clinically significant improvements were obtained for 70% of the children at posttest and 77% at follow-up. Our study suggests that metacognitive therapy for children with generalized anxiety disorder may be a highly promising treatment approach.
KW - Children
KW - Disorder-specific treatment
KW - Efficacy
KW - Generalized anxiety
KW - Metacognitive therapy
U2 - 10.1016/j.janxdis.2017.11.002
DO - 10.1016/j.janxdis.2017.11.002
M3 - Journal article
C2 - 29145078
VL - 53
SP - 16
EP - 21
JO - Journal of Anxiety Disorders
JF - Journal of Anxiety Disorders
SN - 0887-6185
ER -
ID: 203860460